All posts

The Stars Group has 73 per cent upside, Echelon Wealth says

The Stars Group Inc. (The Stars Group Stock Quote, Chart TSX:TSGI, NASDAQ:TSG) just received clearance for its acquisition of British gaming company Sky Betting & Gaming, an event which should begin to turn the stock around, says analyst Gianluca Tucci with Echelon Wealth Partners, who on Thursday reiterated his “Buy” rating and C $50.00 target price.

TSGI has had an up-and-down year in 2018, with its share price hitting a high of C$51.75 on June 21 only to tumble over ensuing weeks and months to where it now sits at C$29.72 as of late-day trading on Thursday. (All figures in US dollars unless noted otherwise.)

But the downturn could be reversed now that the Sky Betting & Gaming deal, announced in April, has received clearance from Britain’s Competition & Markets Authority, says Tucci.

“With this clearance, TSGI can now start to integrate SkyBet into its operations and begin to realize its expected minimum $70 million in savings,” the analyst states in a client update. “Pro-forma revenue mix is very balanced with ~35 per cent sports betting, ~34 per cent poker, and ~28 per cent casino. We believe we will see a significant chunk of the $70 million in savings in 2019, with 2020 illustrating a full run-rate.”

Tucci notes that The Stars Group is a stable market leader in poker and that its Casino segment should grow to more than $550 million in 2018, while its BetStars sportsbook platform should continue to gain market share as TSGI cross-sells to its over 117-million-strong user base.

The analyst sees The Stars Group generating revenue and Adj. EBITDA in 2018 of $2.10 billion and $789 million, respectively, and revenue and Adj. EBITDA in 2019 of $2.80 billion and $1.08 billion, respectively.

“TSGI is currently trading at a C2018E EV/Sales, EV/EBITDA, and P/E of 2.7x, 7.2x, and 10.2x, respectively, versus its Global Gaming comparables average of 2.7x, 9.2x, and 17.3x, respectively,” he writes.

Tucci’s C$50.00 target represents a projected return of 73 per cent at the time of publication.

Tagged with: tsgi
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Cannara Biotech is a buy, Research Capital says

Research Capital analyst Greg McLeish said in a July 29 update that Cannara Biotech (Cannara Biotech Stock Quote, Chart, News,… [Read More]

12 hours ago

Ahead of Q2 results, is Tantalus Systems a buy?

Beacon Securities analyst Gabriel Leung noted in a July 30 report that Tantalus Systems (Tantalus Systems Holding Stock Quote, Chart,… [Read More]

12 hours ago

Sanuwave Health is a buy, Roth Capital says

Roth Capital Markets is initiating coverage of Sanuwave Health (Sanuwave Health Stock Quote, Chart, News, Analysts, Financials NASDAQ:SNWV) with a… [Read More]

12 hours ago

Shoulder Innovations is an IPO to watch, this analyst says

Roth Capital Markets analyst Jason Wittes noted in a July 28 pre-IPO report that Shoulder Innovations, a new entrant in… [Read More]

13 hours ago

Nextracker wins price target raise at Roth

Roth Capital Markets analyst Philip Shen said in a July 28 earnings preview that Nextracker (Nextracker Stock Quote, Chart, News,… [Read More]

13 hours ago

Telus is my top telecom stock, Brian Madden says

Brian Madden, Chief Investment Officer at First Avenue Investment Counsel, said on BNN Bloomberg’s Market Call on July 25 that… [Read More]

1 day ago